Insufficient scRNA-seq data for expression of LRRC15 at single-cell level.
Insufficient scRNA-seq data for expression of LRRC15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 58% | 155.31 | 268 / 459 | 93% | 93.82 | 1036 / 1118 |
skin | 90% | 1404.06 | 1624 / 1809 | 47% | 12.49 | 224 / 472 |
stomach | 79% | 210.04 | 284 / 359 | 54% | 10.62 | 155 / 286 |
lung | 68% | 218.80 | 391 / 578 | 61% | 16.24 | 702 / 1155 |
intestine | 67% | 257.80 | 649 / 966 | 42% | 8.99 | 222 / 527 |
thymus | 89% | 401.29 | 584 / 653 | 17% | 4.03 | 104 / 605 |
esophagus | 39% | 84.81 | 565 / 1445 | 37% | 10.49 | 67 / 183 |
bladder | 29% | 96.10 | 6 / 21 | 41% | 9.31 | 206 / 504 |
pancreas | 2% | 1.32 | 6 / 328 | 61% | 17.60 | 108 / 178 |
adipose | 58% | 247.19 | 699 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 14.21 | 25 / 45 |
ovary | 19% | 29.38 | 34 / 180 | 36% | 9.65 | 155 / 430 |
lymph node | 0% | 0 | 0 / 0 | 48% | 7.32 | 14 / 29 |
uterus | 21% | 24.08 | 35 / 170 | 19% | 7.67 | 87 / 459 |
blood vessel | 36% | 159.71 | 477 / 1335 | 0% | 0 | 0 / 0 |
prostate | 27% | 38.86 | 67 / 245 | 1% | 0.26 | 4 / 502 |
spleen | 27% | 45.40 | 65 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 13% | 15.67 | 33 / 258 | 3% | 0.59 | 8 / 230 |
heart | 15% | 17.14 | 132 / 861 | 0% | 0 | 0 / 0 |
liver | 5% | 5.38 | 12 / 226 | 1% | 0.22 | 6 / 406 |
muscle | 7% | 14.86 | 53 / 803 | 0% | 0 | 0 / 0 |
kidney | 2% | 2.45 | 2 / 89 | 4% | 1.57 | 36 / 901 |
brain | 2% | 2.42 | 62 / 2642 | 1% | 0.35 | 10 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046813 | Biological process | receptor-mediated virion attachment to host cell |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0046597 | Biological process | negative regulation of viral entry into host cell |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0043236 | Molecular function | laminin binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0005518 | Molecular function | collagen binding |
GO_0001968 | Molecular function | fibronectin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LRRC15 |
Protein name | Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib) |
Synonyms | LIB |
Description | FUNCTION: (Microbial infection) Modulates the ability of SARS-CoV-2 to infect host cells through interaction with the spike protein . Does not act as a SARS-CoV-2 entry receptor but sequesters virions and antagonizes in trans SARS-CoV-2 infection of ACE2(+) cells when expressed on nearby cells . . |
Accessions | Q8TF66 ENST00000347624.4 [Q8TF66-1] ENST00000428839.1 [Q8TF66-2] |